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The enthesis is a complex anatomical and functional interface between tendon and 
bone.  Once injured, this site does not readily heal and is repaired with limited success.  
To aid in repair of the enthesis a commercially available scaffold was chosen, from 3 
candidate biomaterials, with fibroblast and osteoblast deposited extracellular matrix 
(ECM) to create a tendon and bone region, respectively, on the scaffold.  To further 
enhance the ECM deposition, the seeded scaffold was mechanically stimulated in a 
custom built bioreactor for 35 days.  The scaffolds were then evaluated by looking at 
tissue specific gene activation of mesenchymal stem cells (MSC)s due to the deposited 
ECM.  
Out of the three materials, non-degradable polyester fabric (PET), degradable 
polylactic acid (PLA) fabric, and biologic acellular dermal matrix (ACDM), the PLA 
fabric had the best combination of ECM deposition and mechanical strength for the 
project.  After selecting a scaffold, we determined the parameters for co-culture medium, 
with respect to fibroblast and osteoblast mineralization.  It was determined that standard 
growth medium, alpha-MEM + 10% fetal bovine serum + 1000 U/mL penicillin, 1000 
μg/mL streptomycin, 2.5 μg/mL amphotericin-B + 3 mM beta-glycerophosphate + 25 
μg/mL of ascorbic acid provided low fibroblast mineralization while still allowing for 
osteoblast mineralization. Fluorescence imaging demonstrated that a co-cultured scaffold 
could be seeded to produce two distinct tissue specific regions.  The transition zone 
produced had values for collagen and glycosaminoglycan (GAG) deposition between that 
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of the two tissue specific regions.  Lastly after mechanical conditioning, stimulating the 
entire scaffold produced an increase in cell number, and the ratio of collagen to GAG in 
ECM compared to static culture.  When the MSCs were exposed to the tissue specific 
regions, entirely stretched ECM caused an increase in collagen and tendon-specific GAG 
gene activation and a decrease in mineralization gene activation compared to tissue 
culture plastic.  Cartilage specific markers were unchanged.   
In conclusion, a suitable commercially available scaffold was identified.  The 
scaffold was seeded so a tendon specific and bone specific regions were distributed on 
the scaffold.  Mechanically conditioning the scaffolds in a bioreactor increased the 
activation of tissue specific genes for tendon and bone compared to stem cells seeded on 
tissue culture plastic.  Future work includes a functional scaffold testing in an in vivo 
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CHAPTER 1:  INTRODUCTION 
Anatomy and Problem 
The enthesis (or tendon/ligament to bone interface) is a complex tissue interface 
that attaches tendon or ligament to bone1.  This interface is a continuous transition from 
tendon or ligament, to non-mineralized fibrocartilage, to a mineralized fibrocartilage to 
bone1-3.  The function of the enthesis is to transfer loads from tendon to bone, both of 
which have different mechanical properties2,4.  Much of how the mechanical loads are 
transferred is due to the anatomical specificity of the tissue shown in Figure 14.  Tendon 
is comprised of highly aligned collagen fibers in the direction of mechanical loading4,5.  
Most of the tendon fibers are composed of collagen type I and type III as well as 
approximately 2-4% elastin4-6.  There are also proteoglycans such as decorin and 
biglycan that act as crosslinkers within the tendon extracellular matrix (ECM) to aid in 
increased mechanical strength4,7.  This ECM is maintained by specialized fibroblasts 
called tenocytes.  Fibrocartilage is comprised of mostly collagen type II, with small 
amounts of collagen type III and less collagen type I and type X4,5,7.  The collagen fibers 
become larger and alignment becomes less organized from tendon to fibrocartilage.  
Ovoid but aligned cells appear and there are higher amounts of aggrecan compared to 
other proteoglycans present in the fibrocartilage4,8.  This layer transitions into mineralized 
fibrocartilage where round chondrocytes are present in a mineralizing matrix containing 
collagen type II and high amounts of collagen X and aggrecan5,7.  The collagen matrix in 
the mineralizing region is much less organized than the fibrocartilage and tendon.  
Finally, bone is comprised of highly mineralized unaligned collagen type I matrix and no 
collagen type II4.  This matrix is maintained and remodeled by osteoblasts, osteoclasts, 
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and osteocytes7.  This gradual transition from highly aligned non-mineralized tendon to 
low alignment and high mineralization bone is important to relieve stress concentrations 
that could form between an abrupt transition from tendon to bone5.  Even so, there are 
sites in the body that are prone to injuries at the enthesis.  Notably these are the 
supraspinatus tendon in the rotator cuff of the shoulder and the anterior cruciate ligament 
(ACL) in the knee.   
The rotator cuff is an arrangement of tendons that help stabilize the glenohumeral 
joint of the shoulder9.  There are high numbers of injuries of the rotator cuff as people 
age.  It has been estimated that 17 million people have rotator cuff tears and greater that 
30% of the population over the age of 60 years have a rotator cuff tear of which 7-27% 
are full thickness tears and 13-37% are partial thickness tears5,9,10.  To repair these 
injuries, approximately 75,000 surgeries are performed in the United States each year5,10.  
However, there is no gold standard for the treatment of rotator cuff tears.  This is because 
of the complex anatomy of the shoulder and the relatively avascular tendons in the rotator 
cuff that do not lend to natural healing9,10.  The most common method for repair is to 
secure the tendon to the humeral head with sutures and suture anchors, followed by 
extensive rehabilitation therapy5,11.  However, these methods have a reported failure rates 
of 20-70%9-12.  Even though the torn tendon is effectively replaced at its anatomic 
footprint, the functional interface is not regenerated5.  It is the goal of rotator cuff repair 
is to restore the anatomic insertion of the tendon attachment which is the same goal for 




The ACL is the most commonly injured ligament in the knee with an estimated 
100,000 reconstructions per year in the United States and this number is steadily rising 
especially in the aging and the increasingly active younger populations3,5,7.  Injury to the 
ACL causes instability of the knee and causes complications if not treated.  Similar to the 
rotator cuff, the ACL is avascular and does not heal naturally3,7.  For severe tears, 
primary reattachment is difficult so autografts or allografts are used.  The most common 
graft is a bone-tendon-bone (BTB) graft taken from the patella and tibia in the knee of a 
cadaver or patient5,13.  A bone tunnel is formed at the injured site between the femur and 
the tibia and the bone portion of the BTB is secured in the tunnel13.  Another common 
technique is to harvest a hamstring tendon from cadaver or patient and secure it in the 
bone tunnels between the femur and tibia5,13.  Successful repair can be achieved with 
these methods but also come with additional problems.  Autografts are associated with 
additional patient surgeries, donor site morbidity, chronic joint pain, and 
osteoarthritis3,5,7,14. Allografts do not have these problems but do have limited 
availability, increased cost with sterilization, possible donor sourced pathogens, and 
decreased biological and mechanical properties through tissue processing3,5,14.  The 
disadvantages of current graft methodologies reveal a clinical need to develop a graft that 
has the mechanical properties to transfer loads between tendon and bone while having the 
biologic capability to regenerate the anatomical interface needed for functional 
attachment.  Biomaterial and cell based tissue engineering techniques have been used to 
address this problem15.  In addition with the similarities between tendon and ligaments, 
with respect to anatomy, attachment site, and healing behaviors, a single technology 
developed for one could easily be modified for use with the other. 
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Current Research Strategies 
Tissue engineering is the application of biomaterial scaffolds, cells, and signals to 
create a tissue in vitro16.  Tissue engineering techniques are the primary method used in 
research to address enthesis repair and each component has an impact on what tissue is 
formed and how that tissue functions13,17.  The purpose of the scaffold to act as a three-
dimensional structure to allow cell attachment, cell migration, expression of cell signals, 
ECM deposition, and transfer of mechanical loads from surrounding tissues6,18,19.  
Ideally, this biomaterial matches the mechanical properties of the tissue being engineered 
and is degradable so that as the biomaterial scaffold is broken down, regenerated tissue is 
replaced.  However, typically these two characteristic are inversely related with respect to 
mechanical properties11.  Even so, commercially available synthetic materials used for 
tendon-to-bone repair include and non-degradable and degradable polymers.  Non-
degradable materials include polyester terepthalate (PET), polytetraflouroethylene 
(PTFE), and polypropylene (PP) and polycarbonate poly(urethanurea)10,20-23 and 
degradable synthetic materials include poly(urethaneurea), and polylactic acid (PLA) 
10,12,19.  These synthetic materials are attractive as scaffolds because material processing 
allows for control in 3-D structure and porosity which can have large impact on the tissue 
integration and mechanical properties of the repair.  ECM is also a powerful signaler for 
tissue regeneration, so biologic ECM-based scaffolds have been considered2,24.  
Commercially available biologic ECM based materials include acellular dermal matrices 
(ACDM) from human, bovine, porcine, or equine sources9-11,25.  These materials have 
shown rapid degradation and tissue integration but do not have the mechanical properties 
necessary to address functional loading.  The scaffold needs to have tissue-specific 
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structural features for functional repair but also needs to be compatible with tissue-
specific cell types. 
Cells are important in tissue repair as they are responsible for matrix remodeling 
and tissue maintenance4.  Most cell types have been differentiated to a specific function 
depending on the tissue.  For tendon and ligaments, the primary cells are specialized 
fibroblasts, cartilage and fibrocartilage tissues contain chondrocytes, and bone has 
osteoblasts and osteoclasts.  One strategy for cell selection in tissue engineering is to 
choose the fully differentiated cell type to deposit the ECM on the scaffold26.  This is an 
attractive choice because these cell types tend to deposit mimetic ECM components seen 
in the natural tissue26.  However, some specialized cells, such as tenocytes, have low 
metabolic activity, proliferate slowly, and are more suited for ECM maintenance rather 
than regeneration.  Other fibroblast sources, such as dermal fibroblasts have been 
investigated for tendon and ligament repair27.  Results showed that the dermal fibroblasts 
did produce ECM similar to the native ECM27.  For bone tissue engineering typically 
only osteoblasts, bone forming cells are used in the absence of osteoclasts, bone 
resorbing cells.  The other cell selection is an undifferentiated cell source.  Specifically, 
for musculoskeletal tissues, mesenchymal stem cells (MSC) are used6.  MSCs are adult 
stem cells that can differentiate into different cells types depending on the growth factors, 
cytokines, and ECM present24.  MSCs are also metabolically active and deposit collagens 
readily24.  However, MSCs need specific growth factors or chemical signals to fully 
differentiate into a specific cell type6.  As of yet there are no established best cell type for 
each tissue.  Many combinations of scaffold and cell type have the potential to show 
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tissue regeneration but depends on how the scaffold and cells signal the tissue to 
regenerate. 
Extracellular matrix, growth factors, and mechanical stimuli are the signals that 
communicate to the body what to activate or deactivate in order to repair or regenerate 
the injured site24.  Each cell type responds to specific combinations of signals from the 
extracellular environment to maintain or repair the tissue.  Once these signals are 
identified they can be isolated, purified, and re-introduced into the tissue or cell 
environment, sometimes with dramatic effect24.  For example, bone morphogenic protein-
2 (BMP-2) is one growth factor that is commonly used for bone regeneration and when 
introduced into a muscle pouch is able to induce bone formation in the surrounding 
tissue.  Similar responses with respect to tendon have been observed in tendon repair with 
the growth factor, BMP-12.  Other growth factors are equally effective for their specific 
task2.  In addition, mechanical stimuli can have a large impact on tissue response2.  The 
classic example of how mechanical forces can affect tissues is Wolff’s law in bone28.  
Essentially, bone will remodel according the forces acted upon the bone, so increases in 
cyclic forces will induce bone formation and decreases in stimulation will enhance bone 
resorption.  There is also a similar response in tendon and soft tissues where tendon mass 
and ultimate strength increases with increased use and vise versa2,29.  These techniques 
have been utilized by highly controlled mechanical strains systems to accurately control 
the application forces, the strain rates, the number of cycles, temperature, gas exchange, 
and remain sterile while in operation 2,11,30.  How these parameters are actually controlled 
is varied, but several researchers have taken on the challenge of creating these 
mechanical bioreactors to understand the role of mechanical stimulation in tissue 
7 
 
engineering27,30-37.  These effects from the stimulation are most likely specific to each cell 
type and biomaterial scaffold combination used.  Overall, tissue engineering is a complex 
and specific method to regenerate tissues.  The complexity increases when multiple tissue 
types being engineered, such as the enthesis.  With the right combination of scaffolds, 
cells, and signals, the body can be directed to regenerate the functional interface. 
Hypothesis 
The purpose of this research to explore a combination of biomaterial scaffolds, 
cell types, and ECM signals with tissue engineering techniques to aid in the repair of 
tendon-to-bone interfaces of both civilians and soldiers.  We hypothesize that a 
commercially available scaffold can be modified with mechanically stimulated tissue 
specific ECM to induce faster tissue integration than the scaffold alone to aid in repair of 
the tendon-to-bone interface. 
Specifically in this project, integration will be aided by modifying current 
commercially available scaffolds targeted for tendon repair with tissue-specific coating of 
cell deposited ECM.   Distinct regions for tendon and bone will be formed on the scaffold 
using fibroblasts to deposit ECM to create a tendon region and osteoblasts to deposit 
ECM for the bone region.  We then apply varying mechanically stimulation parameters to 
condition the cells while they deposit the ECM on the scaffolds.  Chapter 2 focuses on 
the identification of the biomaterial scaffold from three commercially available materials.  
Chapter 3 describes the development of the co-culture protocol and characterization of 
co-cultured ECM coated scaffolds.  Chapter 4 describes the methodology of applying 
mechanical forces to the cell seeded scaffold, characterizes ECM deposition on the 
scaffold and how that ECM activates tissue specific genes in MSCs.                               
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Tissue Engineering has become commonplace in biomedical research and 
regenerative medicine.  Tissue engineering techniques have been established to create the 
paradigm consisting of combinations of scaffolds, cells, and signals1.  Attempts to create 
various tissues in vitro have been reported by changing the scaffold’s material, structural 
and mechanical properties, the cell types seeded, or the mechanical and chemical 
signals2.  Often these reports have been focused on engineering single tissue types in 
vitro but recently a growing focus on the tissue engineering of multiple tissue types, or 
interfaces of tissues are being explored3,4.  The targeted application has been on 
functional repair of interfaces of musculoskeletal tissues especially at the boundary 
between cartilage to bone, muscle to tendon, and tendon/ligaments to bone3,5.  The work 
in this study focuses on the tendon/ligament to bone interface.   
The tendon to bone interface, called the enthesis, transitions from a highly 
oriented non-calcified tension-based tissue to a calcified compression-based tissue in a 
very short distance6-8.  The body achieves this transition naturally through a direct 
insertion6. Direct insertions accomplish attachment through a four layer transition from 
tendon to fibrocartilage to mineralized fibrocartilage to bone7-10.  Examples of a direct 
insertion that are also sites of orthopedic intervention include the supraspinatus tendon of 
the shoulder rotator cuff and the anterior cruciate ligament in the knee7,8.  The problem 
with these direct insertions for tendon to bone is that they are mostly avascular which 
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make natural repair difficult7,11,12.  Tendon has specialized fibroblasts, called tenocytes, 
which have low metabolic activity and low healing capabilities and are used for 
maintenance of tendon extracellular matrix (ECM) and not necessarily tissue 
regeneration11,13.  Since injuries at these interface sites do not heal well, surgery is often 
the best option for repair6,7,11,12,14.  Grafts are necessary to regain mechanical function for 
very serious injuries7.  Currently, autografts are considered the gold standard but have 
complications of their own including: extra harvesting surgeries, donor site morbidity, 
and increased risk of infection12,13,15,16.  Allografts are also used clinically but are 
associated with possible immune rejection, problems with cellular infiltration, and 
incorporation into the surrounding tissues12,13,15,16.  Synthetic grafts may provide an 
opportunity to engineer the mechanical properties to achieve fixation and include 
biologic components to aid in tissue integration.    
In tissue engineering, the role of the synthetic grafts is as a biomaterial scaffold to 
act as a three-dimensional structure to allow cell attachment, cell migration, expression of 
cell signals, extracellular matrix (ECM) deposition and transfer of mechanical loads from 
surrounding tissues13,17,18.  There have been different scaffolding materials that have been 
tested in vitro and in vivo to improve tendon to bone fixation.  Commercially available 
materials that have been used for tendon to bone repair include various braids, wovens, 
and knits of non-degradable polyester terepthalate (PET), polytetraflouroethylene 
(PTFE), and polypropylene (PP) and polycarbonate poly(urethaneurea)19-23.  Degradable 
synthetic materials that have been used include poly(urethaneurea), and polylactic acid 
(PLA) 18,23,24.  Commercially available biologic ECM based materials include acellular 
dermal matrices from human, bovine, porcine, or equine sources23,25,26.  These devices 
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have been approved by the FDA because they are single biomaterials or, in the case with 
dermal matrices, labeled as tissues26.  Other devices which are gaining interest are 
combination devices of a biomaterial with growth factors or biologic factors including 
cells.  These combination technologies could take up to a decade or more to gain 
regulatory approval.  There may be an opportunity to expedite therapeutic technology 
through the FDA by modifying a commercially available graft with decellularized ECM 
coatings to accommodate the mechanical and biologic needs of the tendon-to-bone 
interface.    
Specifically in regards to this study, integration will be aided by modifying 
commercially available scaffolds targeted for tendon repair with a tissue specific coating 
of cell deposited ECM.  Fibroblasts will be used to deposit ECM to create a tendon 
region and osteoblasts will be used to deposit ECM for the bone region.  This study 
focuses on single culture of both fibroblasts and osteoblasts to evaluate a non-degradable, 
degradable, and biologic substrates as candidates for a tendon to bone interface scaffold.  
After 28 days in culture, the scaffolds will be evaluated quantitatively and qualitatively 
for mechanical properties, cell survival, and ECM deposition.      
METHODS 
Materials 
Representative commercially available degradable, non-degradable, and biologic 
scaffolds were selected for testing.   Fabrics were also targeted due to the high surface 
area and tensile strength inherent in the fabric structure.  The non-degradable custom 
fabric scaffold is polyethylene terephthalate (PET) [Biomedical structures, Warwick, RI] 
and has been previously used in research in our laboratory.  The degradable fabric is X-
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Repair®, a commercially available polylactic acid (PLA) woven fabric provided by 
Synthasome Inc, CA.  X-Repair® is currently used for surgical reinforcement for tendon 
rotator cuff repair.  The biologic representative is BioTape® (BT), an acellular porcine 
collagen dermal matrix provided by Wright Medical Technology, TN.  BioTape® is 
currently used for reinforcement of tendons at suture sites after repair. 
The BioTape samples come sealed in sterile packaging, so additional cleaning and 
sterilization were not necessary.  Care was taken to keep the BioTape sterile using aseptic 
technique while preparing the samples for cell culture.  The fabric scaffolds were not 
provided in sterile condition so cleaning and sterilization was necessary.  Fabric samples 
were cut to the appropriate size based on the experiment to be performed.  The edges 
were fused thermally to prevent unraveling of the fabric.  The fabrics were sonicated in 
an ultrasonic bath in a 1% by volume triton-x 100 detergent solution to remove any 
possible oils or dirt that may be present after manufacturing.  The samples were well 
rinsed several times in deionized water to remove any residual detergent.  The fabric 
samples were further soaked in 70% ethanol (EtOH) and placed under UV light for 1 
hour, flipped, and repeated for another hour to sterilize the scaffolds.  Samples 
undergoing mechanical testing were not sterilized.   
Mechanical Testing  
Prior to cell culture, the scaffolds were evaluated for basic mechanical properties 
and their potential load bearing capabilities.  Each scaffold type (n=5) was cut to 12.5 
mm width and 50 mm length.  All samples were fully hydrated in phosphate buffered 
saline (PBS) before loading.  Scaffolds were clamped into an Instron 33R-4465 load 
frame (Instron, Norwood, MA) and loaded in tension at a rate of 25mm/min until failure.  
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Measurements were taken using a 500 N load cell at a sample rate of 100 Hz using 
Bluehill 2 software.  The PET and PLA fabrics average fiber diameter was measured 
under microscopy to calculate cross sectional area.  BioTape was measured directly with 
digital calipers (Mitutoyo, Aurora, IL).  The stress strain curve was calculated for each 
test specimen.  The elastic modulus, ultimate strength, and strain at failure was taken 
from the stress strain curve and averaged for each scaffold type.           
Cell Seeding and Culture 
After sterilization, scaffolds were soaked in α-MEM (Hyclone, Waltham, MA) 
containing 10% fetal bovine serum (FBS) (Hyclone, Waltham, MA) for 1 hour prior to 
cell seeding.  Scaffolds and tissue culture plastic (TCP) controls were seeded with NIH 
3T3 mouse fibroblasts (FB) (CRL-1658 ATCC, Manassas, VA) or MC 3T3-E1 mouse 
calvarial osteoblasts (OB) (CRL-2593 ATCC, Manassas, VA) in single culture.   The 
scaffolds were seeded at a density of 1x105 cells/mm2 in 24 well plates.  Cells were 
allowed to proliferate for 5 days to allow cells to migrate over the fabric and BioTape.  
Day 5 is considered time zero, then samples were analyzed at days 1, 7, 14, 21, 28 
afterwards.   At each time point, each scaffold group type had an n=4.  All seeded 
scaffolds were grown in α-MEM containing 10% FBS + 1000 U/mL penicillin, 1000 
μg/mL streptomycin, 2.5 μg/mL amphotericin-B (Gibco, Grand Island, NY).  At every 
medium change, ascorbic acid was freshly added to a concentration of 25 μg/mL.     
SEM Imaging and Live/Dead Staining 
The scaffolds were characterized using scanning electron microscopy (SEM).  
Each scaffold type was imaged with and without cell seeding.  Scaffolds were also 
imaged for cell viability over the course of cell culture.  Both fabric types and TCP were 
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imaged using Live/Dead fluorescent stain (Invitrogen, Grand Island, NY) at days 1, 7, 14, 
21, and 28 for each cell type.      
Matrix Digestion 
At each time point, samples were removed from the 24 well plate and placed in a 
2 mL microcentrifuge tube.  Then 1 mL of a buffered enzymatic digestion solution of 100 
μg/mL proteinase-K (Promega, Madison, WI) was added to each sample.  All samples 
were then placed in an oven at 60°C overnight.  The following day 
phenylmethanesulfonylfluoride was added to a final concentration of 5mM to inhibit 
proteinase-K.  All samples were homogenized using a sonic dismembrator (Fisher 
Scientific, Waltham, MA) and aliquots were taken from each sample to perform DNA, 
GAG, and hydroxyproline (HYP) assays.  Volumes were carefully recorded and 
monitored for normalization during analysis.   
DNA Analysis (Pico Green Assay) 
DNA was analyzed using a picogreen assay (Invitrogen, Grand Island, NY) which 
tests for double stranded DNA and was used as a normalization parameter for the other 
matrix components.  Aliquots of 20 μL were used and the assay was performed according 
to the manufacturer’s instructions.   
Glycosaminoglycan (GAG) Analysis (Alcian Blue) 
GAG content was quantified using an alcian blue (National Diagnostics, Atlanta, 
GA) precipitation reaction 16,27,28.  This assay takes advantage of the precipitates formed 
from the binding of alcian blue to sulfated GAGs.  The precipitates are centrifuged and 
rinsed, then dispersed to read with a spectrophotometer.  Briefly, 300 μL aliquots of 
every sample and the chondroitin sulfate standards were incubated for 2 hours with 500 
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μL of 25mM buffered alcian blue solution.  Samples were centrifuged for 5 minutes at 
16,000xg to form a pellet and aspirated.  Pellets were then rinsed with 40% EtOH/buffer 
solution and recentrifuged for 5 minutes at 16,000xg.  The supernatants were aspirated 
and 500 μL of 10% SDS in water was added to resuspend the pellet.  Samples were 
resuspended using the sonic dismembrator.  The resuspended solutions were transferred 
to a 96 well plate and read on a spectrophotometer (Molecular Devices, Sunnyvale, CA) 
at a wavelength of 620 nm.   
Collagen Analysis (Hydroxyproline assay) 
Collagen content was quantified by direct measurement of the amino acid, 
hydroxyproline 29,30.  Collagen proteins are hydrolyzed to amino acids using 6M HCl, 
amino acids are oxidized to a pyrrole with chloramine-T, and a chromophore is formed 
using Ehrlich’s reagent.  Briefly, aliquots were taken from each sample and the volumes 
were recorded.  The aliquots were mixed with 1 mL 6M HCl and placed in an oven at 
100°C overnight.  The solutions were then transferred to 25 mL Wheaton vials and 5 mL 
deionized (DI) water was added.  Samples were frozen, lyophilized, re-hydrated with 5 
mL DI water, frozen and lyophilized a second time to remove the acid.  Samples were 
rehydrated in 1 mL DI water and aliquots were reacted with chloramine-T solution for 20 
minutes at room temperature.  Then Ehrlich’s reagent, 4-(dimethylamino) benzaldehyde 
dissolved in 2:1 n-propanol: perchloric acid, was added to each sample and reacted for 20 
minutes at 60°C to induce a colorimetric response.  Absorbance was measured at a 





BioTape Considerations      
The third scaffold type is BioTape and it has been segregated from the other 
scaffolds simply because its characterization and response in cell culture was much 
different than the other scaffolds.  The first difference encountered with BioTape is that 
the major determinant we used to evaluate a successful scaffold is deposition of 
extracellular matrix onto the scaffolds surface.  BioTape is already comprised of a dense 
network of dermal matrix which consists of collagen and GAGs plus many other matrix 
proteins26.  Control standard samples (n=12) were dried thoroughly, weighed, and kept in 
sterile PBS for the duration of the 4 week study without cell seeding.  After the study, 
these standards were assayed for DNA, GAG, and HYP.  These amounts were then 
averaged and used to subtract the baseline ECM content from the BioTape samples to 
determine the amount of newly deposited ECM.      
Statistics 
The data for each test were collected and averaged.  BioTape was normalized to 
its pre-study weight.  The non-cultured BioTape controls were used to subtract the ECM 
contribution from the BioTape away from the ECM deposited by the cells.  Both the 
GAG and HYP data for each scaffold was normalized to DNA and error was propagated 
due to normalization.  One-way ANOVA with Student-Newman-Kuels (SNK) post- hoc 
tests were performed on the mechanical testing and BioTape data, and all other data were 








Table 1 shows the mechanical performance of each hydrated scaffold type.  All 
groups are significantly different from each other in maximum load, elastic modulus, 
ultimate strength, and strain at failure.  Compared to the other scaffolds, the non-
degradable PET fabric has the highest elastic modulus at nearly 2 GPa and ultimate 
strength of 326 MPa but also has the lowest load until failure at 78 N due to the smallest 
amount of material contributing to loading.  The degradable PLA scaffold has a larger 
cross-sectional area than the PET and accommodated the highest loads of the three 
scaffolds tested.  The PLA also had an elastic modulus of 1.35 GPa and an ultimate 
tensile strength of 301 MPa, significantly less than the PET.  The hydrated biologic 
BioTape scaffold had the highest cross-sectional area of the scaffolds and at 144 N, 
accommodated almost double the loading of the PET scaffold.  However, once 
calculated, the elastic modulus of the BioTape was two orders of magnitude lower than 
the other scaffolds at 38 MPa and the ultimate tensile strength was an order of magnitude 
lower at 12 MPa.  The strain at failure of the non-degradable PET was significantly lower 
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PET 78.3 ± 4.3* 0.24 2055 ± 118* 326 ± 18* 25 ± 3* 
PLA 240.6 ± 17.7* 0.80 1353 ± 26* 301 ± 22* 38 ± 34 
BT 144.7 ± 18.2* 12.25 38 ± 7* 12 ± 2* 40 ± 3 
Data are presented as means ± standard deviations.   *Within columns, groups are 
statistically different from the other groups, p < 0.01. PET = polyester fabric, PLA = 
polylactic acid fabric, BT = BioTape acellular porcine matrix.  Statistics were not 




Scanning electron microscopy was performed to show topographical differences 
between scaffold types.  Each cell seeded scaffold is presented in Figure 1, with ECM 
deposition early in the growth study.  All scaffolds supported cells and matrix deposition 
was noted on all scaffolds after culture at 4 days.  The surfaces of the fibers in both 
fabrics are smooth with little surface roughness.  This morphology did not hinder cell 
attachment or ECM deposition.  The BioTape was more difficult to assess new ECM 
deposition, as it is already ECM based, however at higher magnification seeded cells 
were observed.  Figure 1 shows comparisons of seeded and non-seeded PLA scaffolds (A 
& D).  Image E shows a cell sheet that became detached from the underlying PET fabric 
during the dehydration and coating step.  Images C and F show BioTape with cells at 
100x magnification (C) and with no cell seeding at 75 x magnification (F).  The surface 




   
 
FIGURE 1.  SEM images of three scaffold types at 4 days.  Early ECM deposition is 
visible on each seeded scaffold.  (A) PLA Fabric with cells – 75x magnification, (B) PET 
Fabric with cells – 100x magnification, (C) BioTape with cells – 100x magnification, (D) 
PLA fabric without cells – 75x magnification, (E) PET fabric with a detached cell sheet 




Live Dead Staining 
Images from Live/Dead imaging of the cells seeded on substrates are shown in 
Figure 2.  Cells proliferated and deposited matrix on the scaffolds over the course of 28 
days.  At each subsequent seven-day time point, the images appeared to become 
increasingly blurry.  It is hypothesized the lack of focus is due to continuous ECM 
deposition that diffuses the light.  It is also difficult to acquire a high magnification image 
of the cells on fibers because none of the scaffolds provide a flat surface.  The fabrics 
have multiple focal planes between the interweaving fibers.  As seen in Figure 3, once a 
focal plane is selected the fibers are translucent which further diffuses the fluorescence of 
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the cells.  Even though the fibers seem to autofluoresce, they do not.  Therefore, the best 
qualitative data were observed from 4x magnification images.  Cells proliferated and 






FIGURE 2.  Series of Live/Dead Images on TCP, PET, PLA with FB.  Images were 
recorded over the 28 day study.  All magnifications are 4x.  Scale bar in every image is 
500 microns.  Cells were seeded at 1x105 cells/mm2.  Cells proliferated until confluence.  




FIGURE 3.  Live Dead image of FB on PLA fabric at Day 7 - 10x magnification.  This 
image demonstrates the multiple focal planes due to the fabric surface as well as the 
fluorescence of the cells observed through the translucent fibers.  The vast majority of 
cells were live (green) while few dead cells (red) were observed.   
 
 
DNA (Picogreen assay) 
The DNA data used for normalization are presented in Figure 4.  Both fabric 
types supported cells but not to the level of the tissue culture plastic control.  DNA was 
present on both scaffolds and TCP over the entire 28 day study. Only the FB had 
significantly higher DNA values for the PLA over the PET scaffold for days 7, 14, and 
28.  There were approximately equal amounts of DNA regardless of cell type indicating 




FIGURE 4.  DNA data [means ± standard deviations] from OB (A) and FB (B) cultured 
on PLA and PET scaffolds and a TCP control (BioTape is presented separately).  With 
respect to the OB, the TCP control was significantly greater than the scaffolds.  There 
was no difference in scaffolds.  For the FB, The TCP was also significantly greater than 
the scaffolds.  On days 7, 14, and 28 the PLA scaffold had significantly more DNA than 
the PET scaffold. *p<0.05.  
 
 
GAG (alcian blue assay) 
Using the alcian blue method, deposited GAG amounts were quantified and 
normalized to DNA.  Figure 5 shows that both scaffold types promoted significantly 
more GAG/DNA than the TCP control for both cell types at most time points.  There was 
no significant difference between PLA and PET scaffolds for OB.  On day 1 PLA fabric 
had significantly more GAG/DNA than the PET scaffolds, however by day 28 PET had 
significantly more deposition per cell.  Day 1 was observed to have a high GAG per cell 
amount when compared with the other time points. This is most likely due to the lower 
DNA amounts on the scaffolds at day 1, so that any GAG present will be amplified.  For 
the remaining time points, GAG per cell tended to remain constant for the osteoblasts or 




FIGURE 5.  GAG data [means ± standard deviations ] normalized to DNA for PLA and 
PET scaffolds and a TCP control for both OB (A) and FB (B).  Both scaffolds had 
significantly more GAG/ DNA than the TCP control for most time points.  There was no 
significant difference between PLA and PET scaffolds for the OB.  PLA supported 
significantly more GAG/DNA than the PET scaffold on days 1 but the PET scaffold had 




Collagen content of deposited ECM was measured using the hydroxyproline 
assay.  Figure 6 shows normalized HYP/DNA amounts for each type on the scaffolds 
(BioTape is presented separately).  For the osteoblasts, with exception of the PET 
scaffold on day 1, there was no significant difference of HYP/DNA for any of the other 
scaffolds on any time point.  With respect to the fibroblasts, the PET scaffold did support 
significantly more HYP/DNA than the PLA scaffold or TCP control.  As seen previously 
with the GAG/DNA data, day 1 was observed to have a high HYP/DNA amount due to 
the lower initial cell numbers on the scaffolds making any deposited hydroxyproline 
seem higher.   For the remaining time points, HYP/DNA tended to slightly increase 




FIGURE 6 – Hydroxyproline data [means ± standard deviations] normalized to DNA for 
PLA and PET scaffolds and a TCP control for both OB (A) and FB (B).  For the OB, the 
PET fabric had significantly higher collagen content per cell on Day 1.  For the FB, the 
PET fabric had significantly higher collagen per cell on day 1, 14, 21 and 28.  There was 




As mentioned previously, BioTape is an ECM based biologic scaffold comprised 
of the same ECM components assayed for in this study.  Therefore, all data presented in 
Figure 7 have been normalized to the 12 standard samples without cell seeding in order to 
subtract out the baseline BioTape signal.  The signal measured from the BioTape 
standards was much higher than the signal detected from the samples with cell deposited 
ECM.  Another complication with normalizing to non-seeded acellular BioTape 
standards was that large amounts of DNA were extracted from the BioTape.  This 
suggests that the DNA is not completely removed from the BioTape matrix25,26 which 
further complicates DNA normalization for the GAG and collagen assays.  Once 
normalized to the BioTape standards, most of the data was near zero or negative.  DNA 
measurements of seeded scaffolds increased over the course of the study for both cell 
types indicating cell proliferation after seeding.  Both GAG and HYP amounts measured 
decreased over the duration of the study.  Once normalized to DNA and the BioTape 
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baseline, the GAG and HYP amounts had steadily decreasing values.  There was a 
significant difference from day 1 to days 21 and 28 for the GAG/DNA for both cell types.  




FIGURE 7 – Both normalized GAG and HYP data [means ± standard deviations] for the 
BioTape scaffolds.  (A) GAG/DNA for OB.  There was a significant decrease from day 1 
to days 21 and 28.  (B) GAG/DNA for FB.  There was no difference between days 1, 7 
and 14.  However, there was a significant decrease with days 21 and 28.  (C) HYP/DNA 
for OB.  There was not a significant decrease in HYP/DNA. (D) HYP/DNA for FB.  




The purpose of this study was to determine an appropriate biomaterial scaffold for 
tissue engineering of the tendon to bone interface for future evaluations.  The scaffold 
options were commercially available candidates chosen to compare characteristics of a 
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non-degradable, degradable and a biologic biomaterial.  The overall function of tissue 
engineering scaffolds is to allow cell attachment, cell migration, expression of cell 
signals, extracellular matrix (ECM) deposition and transfer of mechanical loads from 
surrounding tissues5,31.  As biomaterials, all three scaffolds allowed for cell attachment, 
proliferation and had good cell viability with fibroblasts and osteoblasts based on SEM 
and Live/Dead imaging.  For use in tendon to bone interfaces, the scaffolds need to 
combine the properties of tendon and bone tissue-engineering scaffolds into a single 
construct.  This means balancing mechanical properties and biologic responses of the 
scaffold.  The main cause of graft failure is insufficient functional integration with the 
surrounding tissue to achieve mechanical stability at the interface16.  In the past, PET 
scaffolds were used in ligament repair with limited success20-22.  Scaffolds showed good 
initial fixation and results but long-term the implants loosened at the surgical site and did 
not provide stability.  PET was included in this study because modifying the non-
degradable with a biologic coating may help bridge the mechanical benefits of synthetic 
biomaterials biologic with the benefits of ECM based biomaterials.  
The representative ECM components selected to determine cell based ECM 
deposition on the scaffolds were glycosaminoglycans and collagen.  GAGs are important 
matrix components for stabilizing ECM and collagen fibrils in connective tissues, bind 
water to create hydrostatic pressure, and show general matrix deposition32.  Chondroitin 
sulfate is the most prevalent GAG in bone and is also present in tendon.  GAGs 
participate in other tendon important proteoglycans, such as decorin and biglycan, which 
act as crosslinkers for collagen aiding in an increase of tensile strength 33.  The assay we 
performed, alcian blue, is used in a precipitation reaction with sulfated GAGs to allow for 
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quantification 27,28.  This reaction binds to all sulfated GAGs, but not to non-sulfated 
GAGs.  For the purposes of this study it was not necessary to determine the specificity of 
individual GAGs, since sulfated GAGs are present in both bone and tendon ECM32.  In 
our studies, once the GAG data were normalized to DNA, both of the fabric scaffolds had 
higher GAG deposition per cell compared to the TCP control.  This may be due to the 3-
D nature of the scaffolds that has higher surface area for the cells, rather than forming a 
monolayer sheet on the TCP.  Both cell types deposited significantly more GAG on the 
PET and PLA scaffolds compared to TCP control.  We also found that after the initial 
GAG deposition on the scaffolds, the OB deposited GAG per cell leveled off while the 
FB deposited GAG per cell increased over the study.  A study by Visser et al. using the 
same PLA fabric with primary tenocytes showed that total sulfated GAG amount 
remained unchanged with time18. 
The other ECM component measured was collagen.  It is the major component 
found in connective tissues, especially bone and tendon 3,10,33.  Hydroxyproline comprises 
10.8% of the amino acids in collagen29,30 and is relatively specific to collagen.  However, 
this assay does not distinguish between collagen sub types, such as collagen I, II, and III, 
all of which are found in different parts of the enthesis.  Also while hydroxyproline is 
mostly seen in collagens, it is also 1% of the amino acids found in elastin, another matrix 
component in tendon13.  Elastin exists as  less than 3% of the ECM content in tendon3 so 
it was not a concern for measuring potential small amounts of elastin-contributing 
hydroxyproline along with the major contributing collagen based hydroxyproline.   There 
were not as many differences between scaffolds for collagen deposition.  The fibroblasts 
did deposit significantly more collagen per cell on the PET fabric than the other 
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scaffolds.  It is possible, there may have been some acidic by products34 or small amounts 
of degradation of the PLA over the 4 week study causing less accumulated amounts of 
collagen compared to the non-degradable PET fabric13.  Further testing is needed to 
confirm this hypothesis.   A continuous deposition of collagen on the PLA fabric over 28 
days was also reported by Visser, et al18.  Hydroxyproline is a good first step and 
selection assay for the differing scaffold types.  In future studies, more specific collagen 
subtypes can be studied to distinguish between tendon, bone, and the fibrocartilage 
transition zone. 
ECM accommodation is just one factor in the scaffold selection criteria.  
Mechanical stability is another major factor in whether a scaffold can be a successful 
graft.  The primary cause of graft failure occurs because of mechanical stability at the 
interface junction and lack of functional intergration16.  This is one reason why synthetic 
grafts have been so attractive as scaffolds because the mechanical properties can be 
tailored to suit the needs of the tissue being engineered 12.   The mechanical strength of 
the scaffolds was measured through tensile testing, since tendons are primarily under 
tensile loads.  Depending on which tendon is tested and which methods of testing are 
used, tendon can have a range of mechanical values.  The elastic modulus of tendon 
typically ranges between 500-1850 MPa, strains at failure are between 50-125 MPa, and 
failure strains are 13-32% for bone-tendon-bone specimens or 5-16% for tendon proper35.  
The PET scaffold in comparison has an elastic modulus and ultimate strength that are 
greater than native tendon and a failure strain within the range of a bone-tendon 
specimen.  Similarly, the PLA scaffold has an elastic modulus that falls within the range 
of native tendon and a higher ultimate tensile strength and higher strain at failure than 
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tendon.  It is promising that if a suitable fixation method could be attained then the 
mechanical properties of the scaffolds could accommodate loading until tissue integration 
is achieved.  The biologic scaffold had a mechanical performance significantly lower 
than the other tested scaffolds.  Biologic based scaffolds, such as acellular dermal grafts 
and small intestine submucosa, have not been able to establish mechanical properties 
equal to native tissues, and typically have more than an order of magnitude less than 
tendon25,26.  Our mechanical testing concurred with these previous findings.  It should be 
noted that, as a commercial product, these products, including BioTape, are not designed 
nor indicated for direct loading of tendon, but rather as an augmented wrap around 
tendon sutures to reinforce healing25,26,36.  The aim of this project, however, is to select a 
scaffold that can assist in transferring some of the mechanical loading after repair during 
healing. 
BioTape also had several other in vitro complications associated with analyzing 
the newly deposited or cell mediated ECM because of the high amounts of the baseline 
BioTape ECM.  Another complication is the residual DNA found in the BioTape 
standards which complicates normalization of the ECM components.  Other researchers 
have found that ECM based materials have varying successes of removing cells, cell 
components, and DNA from the ECM 13,25,26.  The third unexpected result is that over the 
course of the 28 day study, with no noticeable breakdown of the BioTape, the ECM 
components that were quantified in the BioTape decreased.  It is possible that the cells 
could begin a remodeling type behavior by excreting MMPs in the form of collagenases 
to breakdown the matrix or to migrate through the tissue37-39, but further evaluations 
would need to be performed to confirm this hypothesis.  While studies using BioTape 
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have reported good in vivo performance25,26, its effectiveness as an in vitro tendon to 
bone scaffold was obscured because of the negative measured ECM values, and high 
ECM baseline signal compared to the newly cell deposited ECM.  There is also a high 
amount of residual DNA that obscures cell quantification and normalization.  
In conclusion, although BioTape is reported to perform well in clinical studies, 
the scaffold was difficult to assay in vitro and did not demonstrate the mechanical 
strength necessary as a directly loaded tendon scaffold.  While the PET and the PLA had 
significantly higher ultimate strengths than the BioTape, the PLA fabric has a modulus 
within the range of reported tendon values.  FB did deposit more collagen on the PET 
scaffolds but based on the other cellular depositions of ECM both fabric scaffolds 
performed very similarly.  Degradable scaffolds do have the added advantage that allow 
for replacement with host tissue as the scaffold degrades.  The non-degradable scaffold 
does not have that opportunity and will be implanted for the life of the patient.  With 
mechanical performance and the ECM deposition being similar between both scaffold 
types, for our application, the degradable PLA fabric scaffold is the most appropriate 
scaffold for the tendon to bone interface and future studies will expand using this 
scaffold.  Future studies include a more efficient cell seeding technique for scaffolds, 
analyzing ECM deposition using more specific ECM components, and co-culture of 
fibroblasts and osteoblasts on a single scaffold to create a more mimetic tendon-to-bone 
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CHAPTER 3: CO-CULTURED TISSUE-SPECIFIC SCAFFOLDS FOR 
TENDON/BONE INTERFACE ENGINEERING 
 
INTRODUCTION 
The tendon/ligament to bone interface, or enthesis has a complex 
structure/organization to enable transfer of forces through the tendon/ligament to the 
bone.  The body naturally achieves force transition through a four layer gradient from 
tendon to fibrocartilage to mineralized fibrocartilage to bone1-4.  Examples of tissues with 
an enthesis include the supraspinatus tendon of the shoulder rotator cuff and the anterior 
cruciate ligament in the knee1,3. Since these enthesis locations are mostly avascular, 
healing after injury is very limited and often requires surgical intervention to repair the 
damage.  There are a reported 30,000-75,000 cases of rotator cuff repair per year in the 
United States5 and an estimated 150,000 ACL surgeries each year6.  In severe injuries to 
these sites a graft is necessary for repair1,6-9.   
Most grafts currently used clinically for repair are autograft or allograft but each 
has its own complications.  Autografts have additional harvesting surgeries, donor site 
morbidity, and increased risk for infection, while allografts have complications with 
possible immune rejection, problems with cellular infiltration, and incorporation into the 
surrounding tissue environment6,10-12.  Synthetic polymeric grafts have been used to 
investigate repair solutions in the ACL since the 1970s and showed good short term 
success but never integrated well into the repair site and ultimately failed13-17.  Current, 
research using tissue engineering principles are widely reported using different 
biomaterials, cell types, and growth factors18,19 .  Focus has been to create different 
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conditions on a single scaffold that can be specific to multiple tissue types20, such as 
muscle to tendon, cartilage to bone, and tendon/ligament to bone.  This strategy can be 
implemented by changing the biomaterial’s chemical or physical structure, the cell source 
or a growth factor signal specific to the targeted tissue, or any combination of the 
above21.        
Ultimately, regardless of tissue application, the scaffold will have to integrate into 
the tissue to transfer the loads of the musculoskeletal tissues to regain function1.  
Specifically in regards to this project, a tendon-to-bone repair scaffold will be made by 
modifying current commercially available degradable scaffold targeted for tendon repair 
with a tissue specific coating of co-cultured cell deposited extracellular matrix (ECM).  
Fibroblasts (FB) will be used to deposit “tendon” ECM and osteoblasts (OB) will be used 
to deposited “bone” ECM.  In this study, we examine the formulation of co-culture 
medium for both cell types with regard to protein deposition and mineralization, seeding 
specificity on scaffold, and ECM characterization on the tissue specific regions of the 
scaffold.      
METHODS 
Medium Determination  
To determine the appropriate co-culture medium formulation with respect to 
mineralization, NIH 3T3 mouse fibroblasts (CRL-1658 ATCC, Manassas, VA) or MC 
3T3-E1 mouse calvarial osteoblasts (CRL-2593 ATCC, Manassas, VA) cells were seeded 
on tissue culture plastic (TCP) in single culture with varying concentrations of beta-
glycerophosphate disodium pentahydrate (β-GP) (MPbio, Santa Ana, CA) to balance 
high OB mineralization with low FB mineralization.  Both cell types were seeded at 
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1x104 cells/cm2 per well in a 12-well plate(BD Falcon, San Jose, CA ) in α-MEM 
(Hyclone, Waltham, MA) containing 10% fetal bovine serum (FBS) (Hyclone, Waltham, 
MA) + 1000 U/mL penicillin, 1000 µg/mL streptomycin, 2.5 µg/mL amphotericin-B 
(AB/AM) (Gibco, Grand Island, NY)  and at every medium change 25 μg/mL L-ascorbic 
acid (AA) (Acros Organics, NJ) was freshly added.  To this formulation 0, 1, 3, or 5 mM 
of β-GP was added.  Medium was changed every 2-3 days.  Seeded plates were cultured 
in an incubator at 37 °C and 5% CO2. At timepoints of 1, 4, 7, and 14 days, medium was 
removed from the plates and samples were frozen at -80 °C until the end of the study, at 
which point 1 mL of biology grade water was added and all cells were lysed  with an 
ultrasonic dismembrator (Fisher Scientific, Waltham, MA).  Aliquots were then taken to 
perform picogreen assay for DNA quantification (Invitrogen, Grand Island, NY), Pierce 
BCA for total protein (ThermoScientific, Rockford, IL), and calcium assay for 
mineralization (Pointe Scientific, Canton, MI).  All assays were performed according to 
the manufacturer’s protocols.  The medium determination experiment, including similar 
concentrations of medium additives and data collection timepoints were based on a 
similar study by Wang et al2.  After the data were collected, total protein and 
mineralization data were normalized to DNA.  All test medium formulations with each 
cell type were evaluated in triplicate at each time point.        
Scaffold Seeding 
The scaffold used for this study is X-Repair®, a commercially available poly-l-
lactic acid (PLA) woven fabric provided by Synthasome Inc, CA.  X-Repair® is currently 
used for surgical reinforcement for tendon rotator cuff repair.  PLA fabric scaffolds were 
cut into strips with dimensions of 10 mm wide by 60 mm long.  The edges were sealed by 
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thermally fusing the polymer so the fabric structure would not unravel.  The scaffolds 
were cleaned with a detergent solution, rinsed thoroughly with deionized water multiple 
times, and sterilized with 70% ethanol and UV light.  Prior to cell seeding, the scaffolds 
were soaked in sterile culture medium containing FBS overnight to aid in cell attachment.  
The scaffolds were seeded with FB and OB in co-culture at a 1x106 cells/scaffold region, 
as shown in Figure 1.  The total number of cells per scaffold was 2x106, one million each 
of FB and OB.  All seeded scaffolds were grown in α-MEM containing 10% FBS + 
AB/AM + 3mM β-GP and at every medium change 25 μg/mL AA was freshly added.  
All seeded scaffolds were kept in an incubator at 37°C and 5% CO2.  
 
   
          
FIGURE 1.  Schematic of how the PLA scaffolds are seeded with FB and OB on co-
culture to make a tendon region and a bone region on the scaffold.  There is a transition 
zone between the two regions where both cells interact.  
 
 
Cell Tracking and Migration 
To track the cells’ location and migration after seeded and to confirm that tendon 
and bone regions can be successfully seeded on a scaffold, the cells were labeled with 
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two different fluorescent stains by a method modified by Wang et al2.  FBs were labeled 
with Cell Tracker Green (Lonza, Alendale, NJ) and the OB were labeled with Cell 
Tracker Orange (Lonza, Alendale, NJ) according to the manufacturer’s protocols.  
Briefly, cells were removed from the TCP flask, collected and centrifuged at 16,000xg 
for 5 minutes to form a pellet.  FBs were resuspended in a 10 mM green tracker solution 
and the OB were resuspended in 10 mM orange tracker solution for 30 minutes and 
placed in an incubator.  Labeled cells were seeded on the scaffolds as described 
previously, shown in Figure 1.  The cells were allowed to attach to the scaffolds for 6 
hours after seeding.  The scaffolds were then placed in a sterile custom made cover glass 
petri dish for fluorescence imaging.  Using an inverted microscope (Nikon, Melville, NY) 
and a motorized stage (ASI Imaging, Eugene, OR) the entire scaffold was imaged by 
taking approximately 200 images at 4x magnification and stitching the images into a 
montage using BioQuant Osteo software (BioQuant, Nashville, TN).  Scaffolds were 
imaged once at excitation/emission (ex/em) of 470nm/515nm then again at ex/em of 
540nm/590nm.  Both images were then merged together with BioQuant.  Images were 
replicated at 6, 18, 30, and 42 hours for cell migration.             
ECM Deposition 
Extracellular matrix on the scaffolds was quantified after 28 days culture to 
characterize and evaluate the matrix deposited by the cells on the scaffolds.  Cells were 
seeded as previously described.  The evaluated and selected culture medium used was α-
MEM containing 10% FBS + AB/AM + 3mM β-GP and 25 μg/mL AA was freshly added 
at every medium change.   All scaffolds were cultured individually in 100mm non-treated 
polystyrene petri dishes.  Scaffolds were moved to new petri dishes every 7 days to 
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prevent cells that migrated off the scaffolds from becoming confluent.  Scaffolds (n=4) 
were collected at timepoints of 1, 7, 14, 21 and 28 days.  At each timepoint, the 10 x 60 
mm scaffolds were removed from the petri dish and cut into three 10 x 20 mm sections.  
Each scaffold, therefore, produced a tendon section, a transition middle section, and a 
bone section for analysis.  Each section was placed in a 1.5 mL microcentrifuge tube and 
1 mL of a buffered enzymatic digestion solution of 100 μg/mL proteinase-K (Promega, 
Madison, WI) was added to every tube.  All samples were then placed in an oven at 60°C 
overnight to digest the ECM.  The following day phenylmethanesulfonylfluoride (PMSF) 
was added to a concentration of 5mM to inhibit the proteinase-K.  All samples were 
homogenized using a sonic dismembrator and aliquots were removed for analysis.  One 
aliquot was used to test for cell number through DNA quantification (Picogreen green 
assay, Invitrogen, Grand Island, NY).  Another aliquot was used to measure the 
glycosaminoglycan (GAG) content (National Diagnostics, Atlanta, GA) through an alcian 
blue precipitation reaction22,23.  The last aliquot was used to quantify collagen content 
through the detection of the amino acid hydroxyproline (HYP)24,25.  All volumes were 
carefully recorded for normalization during analysis.  
Statistics 
The data for each test were collected and averaged.  All assays including Pierce 
BCA, Calcium, GAG, and HYP were normalized to their respective picogreen DNA 
assays for each respective sample.  Then Two-way ANOVA with Holm-Sidak post-hoc 
test was performed on the necessary groups at a significance level of α=0.05 using 





This study had three main objectives:  (1) to determine a suitable medium 
formulation to balance OB to FB mineralization, (2) to demonstrate successful substrate 
seeding in co-culture to create multiple regions on a single scaffold, and (3) to measure 
and quantify the ECM deposited across the scaffold and the difference in co-cultured 
regions. 
Medium Determination 
In the co-culture medium formulation, two additional components were added to 
the standard growth medium formulation, ascorbic acid for collagen deposition and β-GP 
for mineralization.  Ascorbic acid concentration was held constant for all formulations at 
25 µg/mL.  The amount of β-GP was varied in the co-culture medium to look at 
differences in total protein expression and calcium deposition per cell by both FB and OB 
in single culture.  Cell number was estimated from DNA measurements.  Figure 2 shows 
that the FB did not differ significantly in total protein per cell regardless of β-GP 
concentration.  There was only a gradual increase in protein deposition between days 1 
and 14.  The only significant difference is between day 1 and day 14 in the 5 mM group.  
The OB protein deposition was also not significantly affected by the β-GP.  However, 
there were some significant time dependent increases in total protein compared to day 1.  
Overall, β-GP had little effect on total protein deposition which may be more strongly 
attributed to the ascorbic acid 26-28.         
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FIGURE 2.  Average total protein deposition plus standard deviations of (A) FB and (B) 
OB cultured in 0, 1, 3, or 5 mM β-GP.  Each group was measured in triplicate.  There was 
no significant difference in FB or OB total protein deposition with regard to β-GP 
concentration.  There are some significant time dependent effects on protein deposition. 
*indicates statistical significance of p<0.05. 
 
 
There was a more observable effect of β-GP concentration on mineralization in 
the OB cell line.  Within days 1, 7, and 14, the 5mM β-GP concentration produced a 
significantly higher amount of calcium deposition than the other concentrations.  There 
was also a significant time dependent increase (significance is not indicated in the OB 
graph) in calcium deposition for every β-GP concentration.   There was no significant 
difference within each timepoint for β-GP concentration on FB mineralization.  There 
was, however, a significantly higher amount of FB calcium deposition on the day 14 
timepoint compared the other days, with the exception of the 3mM β-GP group.  Due to 
the low fibroblast mineralization to osteoblast mineralization, the 3 mM β-GP 
concentration was used in medium formulations for the subsequent studies.     
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FIGURE 3.  Average calcium deposition plus standard deviations of (A) FB and (B) OB 
cultured in 0, 1, 3, or 5 mM β-GP.  Each group was measured in triplicate.  There was not 
a significant difference between β-GP concentrations in FB mineralization.  There was a 
significant time dependent increase in Day 14 compared to other days.  For OBs, there 
was a significant increase in mineralization of the 5mM concentration for each time point 
compared to the other concentrations.  There was also a significant increase in 
mineralization for all concentrations over time (not indicated on graph).  *indicates 
statistical significance of p<0.05. 
 
 
Fluorescence Imaging of Scaffold Seeding 
The second objective of this study was to investigate seeding a single scaffold in 
co-culture to create tendon- and bone- specific regions.  The FBs were stained with green 
tracking probe and the OBs were labeled with a red tracking probe.  The montage image 
in Figure 4 shows the entire 10 mm by 60 mm scaffold first with the green filter enabled 
then with the red filter.  Each montage is comprised of approximately 200 individual 4x 
magnification images taken with the aid of a motorized stage and stitched together using 
BioQuant software.  As can be seen in Figure 4, both FB and OB are attached on their 
respective half of the scaffold creating the tissue specific regions.  The general tissue 
specific regions at low magnification are easier to distinguish.  Figure 5 contains the two 
non-merged images with smaller selected regions shown at higher magnifications.  There 
are very few FB in the OB region and vice versa.  On the left hand edge of the OB side, 
FB did attach and is more evident at higher exposure times.  However, most cells are 
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located in their respective regions with a decreasing gradient across the scaffold.  There 
was no noticeable migration of cells between regions observed over the 42 hours in 
Figure 6.  The fluorescence label loses intensity over time, and therefore, the exposure 
time was increased by the 42 hour image to intensify the colors on the scaffold.  Because 
of the increased exposure, the 42 hour image has a noticeable amount of unanticipated 
autofluorescence in the periphery of the image.  This is due to the cyanoacrylate used to 




FIGURE 4.  Fluorescent labeled FB (Green) and OB (Red) on the PLA scaffold form 
distinct tissue specific regions at 6 hours.  The two images using the cell tracker green 
and cell tracker orange probes separately were merged to show how the cells are seeded 
on the over entire scaffold.  Image consists of approximately 200 images at 4x 






FIGURE 5.  Image A and B The same two images seen from Figure 4 with higher 
magnification selections shown.  Images C, D, and E show FB in the bone, transition, and 
tendon regions, respectively.  Images F, G, and H show OB in the bone, transition, and 
tendon regions, respectively.  
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FIGURE 6.  Merged fluorescent images over a 42 hour period.  Images show that the 
cells maintain the tissue specific regions on the scaffold.  No noticeable migration was 
observed in the measured time frame.  There are green labeled FB in the bone region and 




The last objective of this study was to quantify the basic components of the ECM 
deposited on the static scaffolds in the tendon, bone, and transition regions.  These 
components are GAGs and collagen measured by alcian blue and hydroxyproline, 
respectively.  Deposited matrix distribution among the different regions the scaffold was 
measured by analyzing equal thirds of the scaffold, creating a tendon, transition, and bone 
specimen per scaffold.  The DNA quantified in Figure 7, indicated no significant 
differences between particular sections representing uniform cell dispersal over the 
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scaffold, including the transition section.  A significant time- dependent difference 
between day 1 and the other timepoints was found.  DNA was used to normalize the 
GAG and HYP data. GAG/DNA measurement was significantly higher in the tendon 
region compared to the other regions on day 14 and day 28.  No significant collagen 
deposition difference between scaffold regions was determined in these static conditions.  
A continual and significantly increasing deposition of collagen over the entire 28 day 
study was found.  This indicates good cell viability and activity on the scaffold.  Even 
though not statistically significant, an interesting observation was that the ECM detected 
in the transition region had intermediate values in between the bone and tendon regions 
and would suggest mixed contributions from each cell type on the scaffold. 
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FIGURE 7.  Quantification of DNA, GAG, and HYP deposition on the co-cultured 
scaffolds.    The scaffolds were sectioned into equal thirds and analyzed separately.  All 
data are mean values plus standard deviations.  Groups were tested with n=4 replicates.  
(A) DNA amounts were not significantly different between the scaffolds regions but it 
did significantly increase from day 1 then stay relatively constant.  (B) There was a 
significantly higher deposition for GAG/DNA in the tendon region compared to the bone 
region for day 14 and 28, with the transition region having intermediate values between 
the two.  (C) There were no significant differences between groups for HYP/DNA 
deposition but there was significantly increasing collagen content over time.  Continually 
increasing collagen deposition is indicative of active and viable cells on the scaffold, in 





The ultimate goal of this research was to create a more effective tissue engineered 
scaffold for tendon to bone interfaces that will integrate with the host tissue, provide 
functional aid while healing, and then degrade overtime as the host tissue replaces the 
scaffold.  The approach taken to achieve this goal was to create a tendon specific and a 
bone specific region on a scaffold using cell deposited ECM on a degradable PLA fabric 
scaffold.  For the tendon region fibroblasts were used and for the bone region osteoblasts 
were cultured on the scaffold.  In this study specifically, a co-culture compatible medium 
formulation was determined, the PLA fabric scaffold can be seeded in a way to create 
two different tissue-specific regions on the scaffold, and deposited ECM in each specific 
region including a transition zone was quantified.   
Other studies have taken similar approaches to repair of musculoskeletal 
interfaces.  Synthetic degradable polymers and ECM components are common scaffold 
choices for tendon/ligament tissue engineering due to control of factors such as 
mechanical properties, pore sizes, degradation properties, and scaffold geometry6,21,29-32.  
For example, to have soft tissue ingrowth into a scaffold a minimum pore size of 200 µm 
has been suggested, while calcified tissue needs a minimum of 100 µm.  Another 
approach to engineering interfaces is changing the cell type involved with the scaffold.  
Osteoblasts are common for bone tissue engineering and specialized tendon fibroblasts, 
called tenocytes, have been used for tendon.  Tenocytes deposit tendon-specific ECM, 
but tenocytes also have low metabolic activity and low healing capabilities which are 
used for maintenance and not necessarily regeneration9,11.  Therefore, other fibroblasts, 
including dermal fibroblasts, have been investigated as well 33.  After choosing individual 
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cell types for the appropriate ECM deposition, introducing the cells into a co-culture 
environment could modify the ECM deposition compared to a single culture.  In one 
published study by Wang et al., they looked at how osteoblasts and fibroblasts interact in 
a co-culture system for a ligament to bone interface, including preliminary experiments to 
determine medium composition and ECM deposition of the co-cultured multiphase set-
up2 similar to our studies.  
The medium formulation of Wang et al., found that 1mM β-GP was optimal for 
low fibroblast mineralization and retained osteoblast mineralization at 7 or 14 days2.  We 
found that 3mM β-GP provided low fibroblast to osteoblast mineralization.  This 
response is most likely cell line specific.  In their study primary bovine cells were used2, 
in comparison, we used well characterized mouse cell lines, NIH 3T3 and MC 3T326.  
The co-culture medium should be tuned to each unique tissue engineering system because 
ECM and mineralization deposition could have impacts on scaffold integration with 
tissues.  For this application, the osteoblast seeded bone region was targeted for higher 
mineralization than the fibroblast seeded tendon region.  It was hypothesized that the 
higher mineral content on the bone side would help provide an environment for 
anchoring the scaffold in the bone.  This approach is a common technique for bone tissue 
engineering which uses minerals like di- and tri-calcium phosphates, or hydroxyapatites 
to signal osteointegration34,35.    Conversely, a low mineralized tendon region is also a 
functional need.  Native tendon is fibrous and non-calcified lending to predominantly 
tensile loading while bone being highly calcified acts mostly in compression 36.  
Conditioning each region properly could help achieve functional loading earlier after 
implantation.   
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Mineralization is not the only important component to the tendon-to-bone 
junction; subtle changes in ECM composition, like elastin, collagens, proteoglycans, and 
GAGs also play a role.  It was observed that the deposition of ECM transition zone on 
our PLA scaffold had average values that were in between the bone region and tendon 
regions values with respect to GAG and collagen.  This finding would indicate that the 
ECM deposition in the center of the scaffold is a mix of osteoblast and fibroblast 
expression.   These initial findings in validating this ECM deposition approach have 
shown promise in establishing tissue specific regions with a small transition.  In future 
studies planned identification of more specific changes with respect to tendon-specific 
and bone-specific ECM deposition will be investigated.  Other reported tendon/ligament 
bone studies have shown how a fibroblast and osteoblast co-cultured scaffold can form 
transitions with characteristics of native tissue between regions.  Wang et al. showed that 
in a co-cultured fibroblast and osteoblast environment an increased collagen type II 
ECM, representative of a cartilaginous zone, was deposited without the presence of 
cartilage forming cells2.  Their approach was taken a step further to include chondrocytes.  
Several successive studies by Spalazzi et al, using degradable multiphasic scaffolds with 
controlled porosity and a tri-culture of fibroblasts, chondrocytes, and osteoblasts 
measured interface specific ECM components in vitro and in vivo to understand the role 
of multiple tissue types in a single scaffold12,37,38.  They have demonstrated the ECM of 
the ligament, fibrocartilage, and bone regions found at the enthesis can be partially 
recreated with in vitro culture.  While no functional mechanical data of the tri-phasic 
scaffolds were reported these experiments are valuable to understanding how cells can 
interact spatially to produce ECM of the enthesis.  In contrast, Ma et al, proposes that 
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because neo-tissue genesis in a tissue engineering process is not exactly the same as 
developmental or wound healing, it is likely unnecessary and impractical for a tissue 
engineered scaffold to completely duplicate the ECM29.  Therefore, an effective therapy 
may not need to fully recreate the tendon, fibrocartilage, and bone ECM in vitro, but 
deposit sufficient specific ECM to direct tissue integration in vivo.  The production of a 
functional repair of the enthesis may need to gain short-term mechanical stability of the 
scaffold in order to initiate mechanical loading while the long-term integration of the 
scaffold is directed by signaling of the tendon-specific and bone-specific ECM coatings.  
A reported study by Encalada-Diaz et al. suggests in the rotator cuff a short-term stability 
with long-term integration may be the case39.   
Previous studies with non-degradable fabric PET scaffolds showed very good 
short term results in ACL repair, but were not able to achieve long-term integration with 
the surrounding tissues13-17.  Applying a tissue-specific ECM coating may help bridge the 
gap between the short-term success of polymer grafts and the long-term integration of 
biologic materials17,40.  For example Recently Li et al., has modified PET ligament 
scaffolds with bioglass and hydroxyapatite to try and increase osseointegration of the 
scaffold into the bone41.  They performed an in vivo bone tunnel study for 2 weeks and 
showed evidence of initial scaffold integration; however, long-term integration was not 
evaluated in their study.   The degradable X-repair PLA scaffold used in our studies 
potentially has an additional advantage over a non-degradable scaffold of slowly 
resorbing over a long-term period while still having short-term mechanical stability 
necessary for some functional loading.  The tissue-specific ECM coatings deposited on 
the PLA scaffold may help integration with the surrounding tissues for successful long-
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term integration.  Eventual investigation with a functional animal model will be 
necessary to fully address this hypothesis.   
In conclusion, the steps taken in this study have aimed to create a cell specific 
extracellular matrix environment on a mechanically robust degradable scaffold to enable 
better fixation of tendinous soft tissues at bony interfaces.  The outlined approach is to 
produce tissue-preferred areas on a scaffold to target the native tissues to integrate with 
the scaffold.  The scaffold will then assist with mechanical loading while the co-cultured 
ECM aids the bodies healing to remodel the wound.  To achieve this goal, we have 
selected a suitable co-culture medium formulation for our initial work with the enthesis 
scaffold.  We were able to seed the scaffold in co-culture to create two distinct tissue 
specific regions on the scaffold.  Lastly, we measured ECM deposition on three regions 
of the scaffold.  Our future work is to increase the specificity of the ECM coating through 
mechanical stimulation of the cell seeded scaffolds while depositing ECM and perform 
more specific ECM analysis.     
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CHAPTER 4:  MECHANICALLY-STIMULATED CO-CULTURED TISSUE-
SPECIFIC SCAFFOLDS FOR TENDON/BONE INTERFACE ENGINEERING 
 
INTRODUCTION 
The tendon/ligament to bone interface, or enthesis, is a complex transition that is 
essential for functional motion as the interface enables the transfer of loads through the 
musculoskeletal system.  The musculoskeletal enthesis is a continuous transition from 
tendon to fibrocartilage to mineralized fibrocartilage to bone1-4  as observed at the 
supraspinatus tendon of the shoulder rotator cuff and the anterior cruciate ligament in the 
knee1,3.  These sites are considered avascular, limiting the healing after injury and often 
requiring surgery for functional repair1,5,6.  Tissue engineering is a mix of biomaterials, 
cells, and biologic signals that can offer a solution for enthesis repair7-9.   However, 
studies have shown that specific minutiae in selecting the tissue engineering factors can 
have impacts on the how the tissues are regenerated10,11.  For example, increasing the 
pore size greater than 150 microns will allow bone tissues to form in the biomaterial and 
tendon tissues require pore sizes greater the 250 microns to form5.  Different cells types 
like fibroblasts, osteoblasts, or chondrocytes deposit their own extracellular matrix 
(ECM) components differing in collagen types and amounts 12-14.  Finally, the effects of 
combinations of growth factors and cytokine signaling can be powerful determinants of 
the tissue type formed in vivo.  For example, bone morphogenetic protein-2 (BMP-2) can 
induce bone formation in a muscle pouch where bone is not naturally found15.  These 
types of growth factors and signals can be useful tools for tissue engineering.  
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One signaling tool for tissue formation that is commonly overlooked is 
mechanical stimulation.  The classic example of how mechanical forces can affect tissues 
is Wolff’s law in bone16.  Essentially, bone will remodel according to the forces acting 
upon the bone, so increases in cyclic forces will cause cells to produce more bone and 
decreases in stimulation will lead to bone resorption.  There is a similar response in 
tendon and other soft tissues such as muscle where an increase in use will lead to an 
increase in mass and ultimate strength while a decrease in use will lead to a decrease in 
mass and tensile strength17 .  Techniques of applying mechanical stimulation to tissues 
have been used in muscle and cardiac tissue engineering18,19.  To apply these mechanical 
strains, systems need to be developed to accurately control the forces applied, strain rates, 
number of cycles, temperature, and gas and nutrient exchange while remaining sterile18.  
How these parameters are actually controlled varies and several researchers have taken 
on the challenge of creating mechanical bioreactors to understand the role of mechanical 
stimulation in tissue engineering6,18-25.  Results from mechanical bioreactor studies have 
determined that the strains, rates, number of cycles, and resting periods can all affect the 
type of ECM deposited6,18-25.  These effects are most likely specific to each cell type and 
biomaterial scaffold used in the mechanical bioreactor.   
In this study, co-cultured tendon-to-bone scaffolds were mechanically stimulated 
in a custom designed bioreactor for 35 days.  It is hypothesized that cyclic mechanical 
stimulation during ECM formation will increase collagen deposition and alignment on a 
fabric substrate and the deposited ECM will cause an increase in tissue specific gene 
markers when mesenchymal stem cells (MSCs) are exposed to the ECM.  A 
commercially available degradable poly-l-lactic acid (PLA) scaffold targeted for tendon 
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repair was stretched over 35 days in a custom built dual strain bioreactor.  Fibroblasts 
were used to deposit “tendon” ECM and osteoblasts were used to deposit “bone” ECM.  
Fibroblast and osteoblast deposited ECM was examined histologically and compared to 
determine the effects of mechanical strain on the morphology and type of ECM produced.  
Once the ECM was deposited on the scaffold, rat (MSCs) were exposed to the ECM 
coating and tissue-specific gene activation was measured.  The ECM of the scaffolds was 
then characterized through quantitative assays and histological analysis.        
METHODS 
Scaffold Seeding 
The tendon repair scaffold used for this study is X-Repair®, a commercially 
available poly-l-lactic acid (PLA) woven fabric provided by Synthasome Inc, CA.  X-
Repair® is currently used for surgical reinforcement for tendon rotator cuff repair.  All 
scaffolds in this study were seeded using the following protocol.  PLA fabric scaffolds 
were cut into strips with dimensions of 10 mm wide by 80 mm long.  The edges were 
sealed by thermally fusing the polymer so the fabric structure would not unravel.  The 
scaffolds were cleaned with a detergent solution, rinsed thoroughly with deionized water 
multiple times, and sanitized with 70% EtOH and UV light.  Prior to cell seeding, the 
scaffolds were soaked in sterile culture medium containing fetal bovine serum 
(formulation described below) overnight to aid in cell attachment.  The scaffolds were 
seeded with NIH 3T3 fibroblasts (FB) and MC 3T3 osteoblasts (OB) in co-culture at a 
1x106 cells/scaffold region, shown in Figure 1.  The total number of cells per scaffold is 
2x106, one million each of FB and OB.  All seeded scaffolds were cultured in α-MEM 
(Hyclone, Waltham, MA) containing 10% fetal bovine serum (FBS) (Hyclone, Waltham, 
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MA) + 1000 U/mL penicillin, 1000 μg/mL streptomycin, 2.5 μg/mL amphotericin-B 
(Gibco, Grand Island, NY) + 3 mM of beta glycerophosphate(β-GP) and 25 μg/mL L-
ascorbic acid (AA) (Acros Organics, NJ).    All seeded scaffolds were kept in an 
incubator at 37°C and 5% CO2 for 24 hours prior to placement in the bioreactor.   
 
 
          
FIGURE 1.  Schematic of how the PLA scaffolds are seeded with fibroblasts and 
osteoblasts on co-culture to make a tendon region and a bone region on the scaffold.  
There is a transition zone between the two regions where both cells interact.   
 
 
Bioreactor and Mechanical Stimulation 
After samples were seeded they were placed in the bioreactor pictured in Figure 2.  
Two separate chambers were used each with 4 scaffolds per chamber.  The FB side of the 
scaffold was placed between the clamps labeled in Figure 2 as (A) and the OB was placed 
in section (B).  One chamber had the adjustable center clamp intact which stretched the 
(A) FB region but not the (B) OB region (now termed FB STIM).  These scaffolds were 
cultured for 21 days with the middle clamp intact then the clamp was removed to allow 
the cells to infiltrate the transition region to deposit ECM and the entire scaffold were 
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stimulated for a further 14 days.  In the second chamber the center clamp was never 
utilized which allowed for the entire scaffold to be stimulated for all 35 days (termed FB 
+ OB STIM).  A stretching regime of 5% cyclic strain at 0.5 Hz for 1 hour per day every 
day was used for the length study.  The culture medium formulation was α-MEM + 10% 
FBS + 1000 U/mL penicillin, 1000 μg/mL streptomycin, 2.5 μg/mL amphotericin-B  + 3 
mM of β-GP and biweekly  25 μg/mL AA was freshly added.  Medium was completely 
refreshed every 7 days.  Both chambers were kept in an incubator at 37 °C and 5% CO2.  
At 35 days, scaffolds were removed from the chamber and decellularized for MSC 





FIGURE 2.  Images of the custom designed bioreactor used for the mechanical 
stimulation studies.  The top image shows the sterile chamber connected to the linear 
actuator with gas permeable medium circulation lines attached.  The bottom left image 
shows a top down view of the inside of the chamber with the actuator arm connected to 
the clamps that hold the scaffolds.  The bottom right image shows the section labeled (A) 
between the actuating clamp and the center adjustable clamp receives mechanic 
stimulation and the section labeled (B) between the center adjustable clamp and the fixed 
clamp does not receive stimulations.  The fibroblast seeded region of the scaffold is 
placed in (A) and the osteoblast seeded region is placed in (B).  The entire chamber and 







Decellularization and Mesenchymal Stem Cell Seeding 
At the end of the 35 days the 10 x 80 mm scaffolds were removed from the 
chambers and cut into three equal sections.  Each scaffold, therefore, produced a tendon 
section, a transition middle section, and a bone section for analysis.  Scaffolds were 
decellularized to remove any fibroblasts or osteoblasts on the scaffolds prior to MSC 
seeding.  The decellularization protocol was a mixture of freeze thaw, hypo- and hyper-
ionic solutions.  First samples were frozen at -80C, thawed and repeated.  The samples 
were alternated in solutions of deionized (DI) water for 1 hour and 10x phosphate 
buffered solution (PBS) for 1 hour.  This cycle was repeated for 6 cycles, placed in DI 
water for one more hour, then soaked in 1x PBS for 1 hour prior to cell seeding.   
Primary rat mesenchymal stem cells (MSC) were isolated from rat femurs as 
previously described26.  These cells were expanded then used at passage 6.  MSCs were 
seeded on each scaffold section at 1x106 cells per section (n=3).  MSCs were also seeded 
on tissue culture plastic (TCP) as a control (n=3).  Samples and cells were cultured in α-
MEM containing 10% FBS + 1000 U/mL penicillin, 1000 μg/mL streptomycin, 2.5 
μg/mL amphotericin-B (Gibco, Grand Island, NY) for 24 hours.  After the 24 hour 
seeding time, scaffolds sections were placed in a sterile PCR grade 1.5 mL centrifuge 
tube and submerged in 0.25% trypsin with EDTA for 10 minutes to release MSCs.  
Scaffolds were removed, medium containing serum was added to neutralize the trypsin, 
and the tubes were centrifuged at 16,000xg for 5 minutes to form a cell pellet.  All liquid 
was aspirated, being careful not to disturb the pellet, then all tubes were immediately 





All PCR work was performed at the molecular resource center (MRC) at the 
University of Tennessee Health Science Center (Memphis TN).  RNA was isolated using 
a RNeasy mini-kit (Qiagen, Hilden, DE) according the manufacturer’s protocol.  RNA 
quality and quantity were measured using a Qubit fluorometer (Invitrogen, Grand Island, 
NY).  After analysis, amplification was deemed necessary.  All RNA was transcribed to 
cDNA using first strand cDNA kit (Roche, Penzberg, DE).  TaqMan PreAmp master mix 
(Invitrogen, Grand Island, NY) was used to amplify the cDNA.  Separate PCR master 
mixes for each gene were then made with custom designed primers (Integrated DNA 
Technologies, Coralville, IA) for Collagen III, Decorin, Osteocalcin, and Aggrecan, as 
shown in Table 1.  All primers were designed for rat genes and hypoxanthine-guanine 
phosphoribosyltransferase (HGPRT) was selected as the best reference gene.  All samples 
plus master mixes were plated out and run for rt-PCR in a Light Cycler 480 (Roche 
Applied Sciences, Penzberg, DE).  After PCR was complete, data was analyzed for 

















Collagen type III Col3A1 NM_032085.1 5’-tcccctggaatctgtgaatc-3’ (forward) 
   5’-tgagtcgaattggggagaat-3’  (reverse) 
Decorin Dcn NM_024129.1 5’-ctccgagtggtgcagtgtt-3’  (forward) 
   5’-gcaatgttgtgtcaggtgga-3’  (reverse) 
Osteocalcin Bglap M23637.1 5’-cattactgaccgctccttcc-3’  (forward) 
   5’-cgcatagcctgtgattttca-3’  (reverse) 
Aggrecan Acan NM_022190.1 5’-aatgggagccagcctacaac-3’  (forward) 




Extracellular matrix deposition on the scaffolds was quantified after 35 days in 
the mechanical bioreactor to characterize the coating.  After the MSCs were removed 
from the scaffolds, each section was placed in a 1.5 mL microcentrifuge tube and 1 mL of 
a buffered 100 μg/mL proteinase-K (Promega, Madison, WI) solution was added to every 
tube.  All samples were then placed in an oven at 60°C overnight to digest the ECM.  The 
following day phenylmethanesulfonylfluoride (PMSF) was added to a final concentration 
of 5mM to inhibit the proteinase-K.  All samples were homogenized using a sonic 
dismembrator and aliquots were removed for analysis.  One aliquot was used to test for 
cell number through DNA quantification (Picogreen green assay, Invitrogen, Grand 
Island, NY).  Another aliquot was used to measure the glycosaminoglycan (GAG) 
content (National Diagnostics, Atlanta, GA) through an alcian blue precipitation 
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reaction28,29.  The last aliquot was used to quantify collagen content through the detection 
of the amino acid hydroxyproline (HYP)30,31.  All volumes were carefully recorded for 
normalization during analysis. 
Histology 
Histology was performed at the University of Alabama-Birmingham Center for 
Metabolic Bone Disease.  After scaffolds had been cultured in the mechanical bioreactor 
and ECM had been deposited across the scaffolds, one FB STIM and one FB+OB STIM 
scaffold was removed from the chamber and frozen.  Samples were then fixed in 10% 
Neutral Buffered Formalin for at least 24 hours, then transferred to 70% ethanol (EtOH) 
for complete fixation. All the samples were dehydrated through cycles of 80% EtOH x1, 
95% EtOH x2, and 100% EtOH x4 then three changes of xylene prior to the infiltration 
solution, 95% methyl methacrylate (MMA) and 5% dibutyl phthalate (DBP).  Infiltration 
solutions for all the samples were refreshed every 3 days, for a total of 4 changes.  After 
infiltration, the samples were embedded on edge in a solution composed by 95% MMA 
and 5% DBP with 0.25% perkodox as the initiator.  The samples were then exposed to 
UV light for polymerization.  The fully polymerized (plasticized) sample blocks were 
trimmed (noting which end was the bone side) and cut to obtain 5 µm thin sections 
through the longitudinal axis.  There were four stains used including 1) Methylene Blue 
and Basic Fuchsin, 2) Goldner’s Trichrome stain, 3) Toluidine Blue stain, and 4) Von 
Kossa stain.  Stained sections were then observed and by light microscopy and captured 






The data was collected and averaged.  The GAG and HYP were normalized to 
DNA and error was propagated32.  Two-way ANOVA with respect to stretching and 
scaffold region with Holm-Sidak post-hoc test was performed on the necessary groups at 
a significance level of α=0.05 using SigmaStat statistical software.  For PCR data, after 
calculating the relative change and propagating error, two-way ANOVA was performed 
on relative changes with respect to scaffold region.              
RESULTS 
This preliminary study has three main objectives: (1) to determine gene activation 
of rat stem cells on the different deposited ECM coatings on the scaffold through rt-PCR, 
(2) to characterize the deposited ECM by measuring collagen and GAG content with 
hydroxyproline and alcian blue methods, respectively, (3) to visually evaluate the 
deposited ECM coating on the scaffolds using histology.     
RT-PCR 
Gene activation of rat MSCs seeded on the mechanically-stimulated scaffolds was 
measured using RT-PCR.  Tendon-specific, bone-specific, and fibrocartilage-specific 
genes were selected for analysis.   Collagen type III, decorin, osteocalcin, and aggrecan 
were measured.  Collagen III is the second most common collagen type in tendon3,33,34 
and is also present in bone.  Decorin is the primary proteoglycan found in tendon33,34.   
Osteocalcin is upregulated during bone formation35.  Aggrecan is the primary 
proteoglycan in cartilaginous tissues3.   Figure 3 shows the relative MSC gene activation 
on the tendon, bone, and transition regions of the scaffold compared to the MSCs 
cultured on TCP.  These data represent activated tissue-specific genes in the MSCs after 
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24 hours of exposure to the ECM coated scaffolds.  This PCR data does not represent 
how mechanical strain affected gene activation during ECM deposition on the scaffolds, 
but how the MSCs react to the mechanically-stimulated ECM deposited coating on the 
scaffolds.  All four genes were upregulated compared to the TCP control.  There were no 
significant differences between any of the experimental groups, shown in Figure 3, due to 
the high variance in the data.  In general, the stretching had a slightly larger impact on the 
osteoblast region ECM compared to the fibroblast region ECM with respect to collagen 
and aggrecan.  It was also observed that full scaffold mechanical stimulation, FB+OB 
STIM, produces a change in deposited ECM to increase MSC collagen activation and 
decrease mineralization activation compared to FB STIM scaffolds.  When the OB region 
is stimulated in the FB+OB STIM scaffolds, there were indications of decreased MSC 
decorin expression compared to the FB STIM scaffolds.  The two different mechanical 
conditioning treatments did not produce a significant difference in MSC aggrecan 





FIGURE 3.  Mean relative fold change with standard deviations of gene activation in 
MSCs exposed to ECM depositions on scaffolds with mechanical stimulation compared 
to MSCs on tissue culture plastic.  Generally, the ECM deposited on the FB+OB STIM 
scaffolds increased activated genes for collagen production, decreased mineralization, 
decreased tendon specific GAG, and no change in fibrocartilage activation compared to 




The ECM deposited on the scaffolds was characterized after removal of the MSCs 
with regards to GAG and HYP deposition which was normalized to DNA.  The FB STIM 
scaffolds were strained with a center clamp in the transition zone of the scaffolds.  
Therefore, while stretching, no cells could grow under the clamp.  After 21 days, the 
clamp was removed to allow cells to infiltrate this transition area for the remaining 14 
days.  While some cells were present in the transition area after 35 days, there was a 
significant decrease in cell number compared to the FB+OB STIM scaffolds.  Generally 
there was more OB DNA than FB DNA on the scaffolds.  Comparing the GAG/DNA for 
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the OB and FB, the different stimulation regimes did not significantly affect ECM 
deposition.  However, there was a significant increase in the GAG/DNA deposition for 
the FB STIM scaffolds compared to FB+OB STIM scaffolds within the transition region.  
A similar trend appeared in the HYP/DNA data.  The two different stretching regimes did 
not significantly affect ECM when comparing between individual regions of the scaffold.  






FIGURE 4.  Characterization of ECM deposited on the scaffolds after 35 days of 
stimulation in the mechanical bioreactor.  A) Mean DNA values ± standard deviation.  B) 
GAG/DNA values ± standard deviation.  C) Mean HYP/DNA values ± standard 









Figure 5 shows a collage of histology slides from the four stains used on the FB 
STIM scaffold sections.  Each image shows the thick ECM layer that was deposited on 
the surface of the scaffolds.  Similar sections of the scaffold were selected for comparison 
between stains.  Each image is a stitched composite of approximately fifty single frames 
at 10x magnification.  Methylene blue and goldner trichrome stained the ECM the most 
intensely.  Within the FB and OB regions a thick ECM layer was found with 
predominately highly aligned collagen and embedded cells as seen in Figure 6.  The 
ECM deposition can be seen directly in contact with the PLA fibers of the scaffold.  In 
some locations, the ECM layer was observed to be physically pulled away from the 
fibers.  This ECM observation was potentially caused during the handling and 
histological processing of the scaffolds.  Also, the majority of the ECM deposition 
occurred at the surface of the fabric layer.  There was evidence of cell penetration and 
collagen deposition deeper within the fabric weave in a few isolated occurrences.  There 
was also a noticeable absence of deposited ECM within the transition area of the FB 
STIM scaffold due to the presence of the center clamp during stimulation.  Upon more 
detailed examination there was no noticeable mineralization in the von kossa or trichome 
staining and no fibrocartilage ECM deposition in the scaffold coating from these medium 




FIGURE 5.  Histological staining of FB STIM scaffolds.  The four stains are listed in 
columns and the scaffold sections are listed in the rows.  The fibroblast “tendon” region 
stained for the most ECM and little to no mineralization.  The center transition was 
positioned under a clamp for 21 days had little observed matrix deposition.  The ECM 
layer is mostly highly aligned collagen seemed to stain more intensely in the FB region of 
the scaffold compared to the OB region.  Mineral staining for early tissue calcification 








FIGURE 6.  Higher magnification (40x) of the collagenous ECM coating on the FB+OB 
STIM scaffolds.  (A) Toluidine blue stain of the ECM coating between the OB and 
transition regions and (B) Goldner trichrome stain of the ECM coating between the FB 
and transition region.  Both images demonstrate multiple layers of highly aligned 
collagen and high cell numbers.  Image B also indicates a lack of fibrocartilage and 
mineral staining.  ECM can be observed in direct contact with the PLA fibers of the 
scaffold, and seems to have been physically separated during specimen slide preparation. 
 
 
Figure 7 shows the collagen from the FB+OB STIM scaffolds.  More intense and 
uniform staining of the ECM coating across the entire scaffold is shown in these 
conditions.  As with the FB STIM, methylene blue and goldner trichrome stained the 
ECM the most intensely, but toluidine blue and von kossa were more intense on the 
FB+OB STIM scaffolds.  ECM deposition in the transition region is intact due to the 
absence of the center clamp during stimulation.  The transition images in Figure 7 show a 
dense cluster on the left side of the scaffold.  This cluster is an indicator thread used to 
mark the midpoint of the scaffold.  Since the thread was easily identified in each image, 
this location was selected as the locale of the transition comparisons.  As with the FB 
STIM scaffolds, the ECM coating consists of a thick ECM layer of mostly highly aligned 
collagen with embedded cells.  Most of the coating is on the surface.  No observed 




FIGURE 7.  Histological staining of FB+OB STIM scaffolds.  The four stains are listed 
in columns and the scaffold sections are listed in the rows.  Similar scaffold sections were 
selected to compare ECM staining.  ECM deposition was uniform on the surface of the 
fabrics for each section, including the transition region.  The dense cluster on the left side 
of the transition region is an indicator thread used to mark the midpoint of the scaffold 
and was an easy target for selecting a comparable location. Collagen was highly aligned 
over the entire scaffold in the direction of the tensile strain.  Little to no mineralization 
staining for any portion of the scaffold was observed under these study conditions.  The 




This study investigated the feasibility of generating a tissue-specific coating on a 
degradable scaffold for tendon-to-bone repair.  The coating is formed by culturing 
fibroblasts and osteoblasts on separate regions of the scaffold and allowing these cells to 
deposit ECM.  The tissue-specific ECM is further enhanced by applying mechanical 
stimulation to the scaffolds and cells over 35 days in culture during ECM deposition.  
This methodology is founded on the hypothesis that specific ECM can direct cells at the 
injury site to regenerate the tissues necessary for enthesis repair36. 
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Biomaterial based scaffolds alone have been used in the past to repair injured 
ligaments at the bony interface in the ACL37-40.  For example, polyester terepthalate 
(PET) scaffolds had promising short term functional results, however long term 
incorporation into the surrounding tissue failed37,41.  ECM based scaffolds like small 
intestinal submucosa (SIS) and acellular dermal matrices (ACDM) are also being used 
clinically to aid in tendon repair42-44.  These materials have shown very good tissue 
integration and injury site remodeling, but these ECM products have much lower 
mechanical properties than natural tendon or bone42-44.  Therefore, a combination of a 
biomaterial based scaffold to achieve short term mechanical stability with an ECM based 
coating to help integrate into the surrounding tissue may provide better clinical outcomes.  
Specific ECM based components are powerful tools in tissue engineering because they 
can provide signals to the body’s cells to regenerate or repair the damaged site36.  
Mechanical stimuli can be applied to the cells in vitro to create a more mimetic ECM 
coating on the scaffold potentially promoting faster scaffold/tissue integration.   
Previous studies using mechanical bioreactors have shown that constructs with 
cell deposited collagen and ECM have increased mechanical strength properties 
compared to static culture 25, although reported conditions of how to apply the 
mechanical stimulation within the bioreactors widely vary.  Strain magnitude, strain rate, 
number of cycles, cycle frequency, and rest durations can all affect the how the cells 
respond, and there is no consensus on the best parameter combination18.  The optimal 
combinations of these parameters are almost certainly specific to the cell types and 
scaffold being used.  Deng et al. reported using static strain to condition dermal 
fibroblasts on aligned PGA fibers24.  Histology showed collagen alignment compared to 
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non-strained substrates and mechanical strength was greatly increased24.  However, 
culture time was 18 weeks which may be too long for a practical therapy.  Cyclic strain 
may produce results faster that static strain but can be dependent upon the strain profile.  
Riboh et al. demonstrated with primary tendon cells, continuous cyclic strain decreased 
cell proliferation, where as intermittent cyclic strain increased cell proliferation and 
increased total collagen production23.  Johsi et al. varied cyclic strain parameters and 
found that ultimate tensile strength of their constructs was highest with relatively low 
cycle frequency and low strain magnitudes of 2.5%.  They found that cell viability 
remained high for the entire study but no ECM characterization was reported25.  Multiple 
studies have shown increases in tendon-specific markers with mechanical stimulation.  
Butler et al. and Abousleiman et al. showed increases in collagens type I and type III with 
direct stimulation of MSCs 6,18and Yang et al. showed the same behavior in primary 
tendon fibroblasts using various stretching regimes21.  The stimulation regime used in this 
study was chosen from average values of parameters described in the literature.  The 
chosen stretching protocol is a good starting point for how mechanical stimulation can 
affect the scaffolds.  Because of the number of variables associated with mechanically 
straining seeded scaffolds, there are future research opportunities to fully optimize the 
stretching protocol for our cell types and scaffolds.   
Our cultured scaffolds demonstrated that collagen became aligned during cyclic 
stimulations and cell viability remained high throughout the study.  There was no 
detectable mineralization in the ECM coating medium.  While any potential in vitro 
calcification deposited was not expected to be mature hydroxyapatite, it was expected to 
see some calcium staining with the Von Kossa stain in the OB region of the scaffold45.  
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Because the scaffolds used in our experiments are co-cultured with FB and OB, the 
osteogenic components were decreased to prevent FB ECM calcification.  A study by 
Alverez-Perez et al. reported no in vitro mineralization of MSC deposited ECM on 
polycaprolactone (PCL) nanofibers when osteogenic medium was not used and positive 
mineralization when osteogenic medium was used46.  It may have been the case that 
osteogenic signals were not strong enough.  While preferential mineralization in the OB 
region compared to FB region would have been appreciated, the focus of this work was to 
modify deposited ECM through mechanical stimulation for a tendon-to-bone repair 
construct.   
Even with the current mechanical stimulation parameters, an increase in tissue 
specific gene activation in MSCs was observed compared to a TCP control.  Increases in 
collagen III, decorin, osteocalcin, and aggrecan activation were all expressed more due to 
the bioreactor conditioned coating.  In a study by Sadr et al, MSC bone specific genes 
were activated more when exposed to cell deposited ECM compared to scaffolds alone 
similar to our findings47.  There are also examples of gradients of ECM based coatings on 
synthetic scaffolds that can spatially upregulate gene activation across the scaffold48,49. 
When comparing actual deposited ECM on the scaffold to our previous tendon/bone 
scaffolds the mechanical conditioning produced a 575-720% increase in FB collagen 
deposition and 250-300% in OB deposition compared to static co-culture conditions 
(REF submissions).  There was also an increase of 8-34% in FB GAG deposition and a 
decrease of 14-30% in OB GAG deposition (REF).  This suggests that the mechanical 
conditioning causes more fibrous deposition in OBs and tendon like behavior in the FB.  
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In conclusion, we have designed and built a mechanical bioreactor that can apply 
different strains on a scaffold for different cell types to produce a more mimetic tissue 
specific coating.  It was observed that stretching regimes in the bioreactor can affect the 
deposited ECM coating on the scaffold and tissue specific genes respond positively to the 
tissue specific ECM coatings compared to tissue culture plastic.  Future work will focus 
on optimizing the stretching protocol for the deposited ECM coatings and evaluate the 
tissue specific coating in a functional tendon-to-bone animal model.   
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CHAPTER 5:  PLANNED IN VIVO ANIMAL MODEL 
Originally outlined in the awarded grant was an in vivo animal model planned to evaluate 
the effectiveness of tissue ingrowth and attachment of a tendon-bone tissue engineered 
scaffold in a rabbit tibial tendon-bone interface.  This animal study had a total of 14 
rabbits with 4 groups:  mechanically-stimulated cultured ECM scaffolds, static cultured 
ECM scaffolds, scaffolds only, and reattached tendon.  Surgeries were performed on 13 
of 14 rabbits with 6 of 13 unexpectedly fracturing legs in less than 72 hours, leading to 
the termination of the study.  These planned studies were based on published articles38 
and approved by proper IACUC and ACURO channels at University of Tennessee, 
University of Memphis, and USAMRMC.  As such, we had no additional funds available 
to repeat a potential modified animal study to re-evaluate the ECM coated scaffolds. 
Therefore, a replacement study of gene activation of MSCs was performed to evaluate the 
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CHAPTER 6:  CONCLUSIONS 
In the scaffolds selection study in chapter 2 we determined that the BioTape 
scaffold had low mechanical strength and degraded before we could quantify ECM 
deposition.  The degradable PLA fabric scaffold was able to provide good mechanical 
strength, while still allowing for high cell viability and deposition of collagen and GAG.  
The non-degradable PET fabric had similar mechanical properties, cell viability, and 
ECM deposition characteristics as the PLA scaffold.  However between the two, the 
degradable biomaterial is a better choice because it allows for replacement with natural 
tissue as is degrades.   
In chapter 3, we determined that with fluorescence cell tracking we are able to 
seed the PLA scaffold in co-culture to make a tendon-specific region and a bone-specific 
region on the scaffold.  We also found a co-culture media formulation of alpha-MEM + 
10% fetal bovine serum + 1x antibiotic/antimycotic+ 3 mM beta-glycerophosphate + 25 
μg/mL of ascorbic acid to ECM deposition with low fibroblast mineralization and still 
provide for osteoblast mineralization.  We also determined that a transition region is 
formed that has collagen and GAG amounts between the fibroblast and osteoblast 
regions.  
In chapter 4, we successfully applied two different strains to a single scaffold to 
stimulate the tendon-region and osteoblast-region differently.  The ECM that was 
deposited on the scaffolds was affected by the different stretching regimes.  There were 
higher cell numbers and higher collagen to GAG ratio on scaffolds where both regions 
were stimulated.  Tissue specific stem cell gene activation was increased on the 
mechanically stimulated scaffolds compared to tissue plastic.   
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We have demonstrated new protocols and methodologies to seed and characterize 
scaffolds for tendon-to-bone tissue engineering.  Also a novel custom dual strain 
bioreactor was designed and developed for use in this project.  These new technologies 
and methodologies will provide opportunities for future investigations and improvements 




CHAPTER 7: RECOMMENDATIONS FOR FUTURE WORK  
The first recommended action is to evaluate the mechanically stimulated tissue 
specific scaffolds in a functional animal model.  I would recommend a model similar the 
one outlined in chapter 5 but with modifications.  It is possible to re-do the study with a 
more proximal bone tunnel in tibia to reduce mid-bone stresses.  The other 
recommendation is to perform the model with smaller scaffolds or use the same scaffolds 
in a slightly larger animal model other than rabbit.  This would reduce the bone tunnel 
needed for a rabbit tibia or allow for a larger tunnel in a bigger tibia of a different animal.  
I would recommend additional and more tissue specific assays to understand the 
deposition of tissue specific ECM on the scaffolds.  We have demonstrated ECM 
deposition of collagen and GAG on the scaffolds.  It would be an advantage to measure 
more specific changes in ECM deposited over the scaffold.  This would allow us 
understand how to modify and improve our methods of cell seeding, media formulation, 
and stretching regimes of the scaffolds.  These more specific assays could include more 
advance direct quantification through ELISA, PCR, or other assays and imaging through 
immunohistochemistry and histology. 
It may be beneficial to move to duplicate characterizations we have learned with a 
different cell line, like primary cells.   It may take a step towards a more mimetic 
assembly of tissue engineering parameters.  There is certainly a large opportunity to 
experiment with different stretching protocols to alter the mechanical signal given to the 
cells during ECM deposition.  We chose a single stretching protocol from the literature, 
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